| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/15/1998 | WO1998001162A2 Gene delivery system |
| 01/15/1998 | WO1998001161A2 Gene therapy delivery system for targeting to endothelia |
| 01/15/1998 | WO1998001160A2 Compositions suitable for delivery of genes to epithelial cells |
| 01/15/1998 | WO1998001159A2 Composition for enhanced uptake of polar drugs from mucosal surfaces |
| 01/15/1998 | WO1998001158A2 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers |
| 01/15/1998 | WO1998001147A1 Medicinal cyclosporin-a aerosol solution formulation |
| 01/15/1998 | WO1998001146A1 Preventives/remedies for stomatitis |
| 01/15/1998 | WO1998001139A1 Injections containing lipid a analogues and process for the preparation thereof |
| 01/15/1998 | WO1998001138A1 Methylprednisolone sodium succinate injections |
| 01/15/1998 | WO1998001124A2 Pharmaceutical preparation containing nimesulide for topical use |
| 01/15/1998 | WO1998001117A1 Sustained release matrix for high-dose insoluble drugs |
| 01/15/1998 | WO1998001113A1 Lubrication assistant and process for the preparation of ethyl stearate used therein |
| 01/15/1998 | WO1998001112A1 New use of a hydrogel formulation |
| 01/15/1998 | WO1998001088A1 Improved tissue injectable composition and method of use |
| 01/15/1998 | DE19646977A1 Stable dry extract of Hypericum perforatum L., Saint John's wort |
| 01/15/1998 | DE19628705A1 Neue Sauerstoff-Transport-Mittel, diese enthaltende Hämoglobin-Hydroxyethylstärke-Konjugate, Verfahren zu deren Herstellung, sowie deren Verwendung als Blutersatzstoffe New oxygen transfer agent containing them hemoglobin-hydroxyethylstarch conjugates, processes for their preparation, and to their use as blood substitutes |
| 01/15/1998 | CA2741501A1 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to grb2 or crk1 |
| 01/15/1998 | CA2260048A1 Improved tissue injectable composition and method of use |
| 01/15/1998 | CA2259433A1 Lubrication assistant and process for the preparation of ethyl stearate used therein |
| 01/15/1998 | CA2258947A1 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers |
| 01/15/1998 | CA2257563A1 Composition for enhanced uptake of polar drugs from mucosal surfaces |
| 01/15/1998 | CA2257408A1 Compositions suitable for delivery of genes to epithelial cells |
| 01/15/1998 | CA2257300A1 Gene therapy delivery system for targeting to endothelia |
| 01/14/1998 | EP0818469A2 Branched cyclodextrins and method for producing them |
| 01/14/1998 | EP0818204A2 Stabilized albumin-free recombinant factor VIII preparation having a low sugar contant |
| 01/14/1998 | EP0818194A2 Lubricant compositions that are spreadable onto and adherable to biomembranes, method of making and use thereof |
| 01/14/1998 | EP0817650A1 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 01/14/1998 | EP0817643A1 Compounds and compositions for delivering active agents |
| 01/14/1998 | EP0817638A2 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers |
| 01/14/1998 | EP0817634A1 Azathioprine compositions for colonic administration |
| 01/14/1998 | EP0817633A1 Transdermal device for the delivery of alfuzosin |
| 01/14/1998 | EP0817628A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 01/14/1998 | EP0817621A1 Pharmaceutical composition for transdermic delivery |
| 01/14/1998 | EP0817619A1 Novel "burst-free" sustained release poly-(lactide/glycolide) mi crospheres |
| 01/14/1998 | EP0817617A1 Microcapsules of predetermined peptide(s) specificity(ies), their preparation and uses |
| 01/14/1998 | EP0817616A1 Pharmaceutical matrix pellets, tablets and composition for the preparation thereof |
| 01/14/1998 | EP0817615A2 Peroral composition for controlled release in the lower gastrointestinal tract |
| 01/14/1998 | EP0817614A1 Stable protein:phospholipid compositions and methods------------ |
| 01/14/1998 | EP0817612A1 Transparent rapid-release preparations of non-steroid analgesics |
| 01/14/1998 | EP0817610A1 Sterile ophthalmological gel preparation applicable in drops and process for producing it |
| 01/14/1998 | EP0604570B1 Compositions containing quinolone antibiotics and sulfonate of polystyrol |
| 01/14/1998 | EP0548088B1 Method of producing semi-solid preparations containing micro-particulate substances |
| 01/14/1998 | EP0394277B1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
| 01/14/1998 | CN1170362A Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours |
| 01/14/1998 | CN1170361A Therapeutic perparation for inhalation containing parathyroid hormone, PTH |
| 01/14/1998 | CN1170358A Chewable dosage forms |
| 01/14/1998 | CN1170356A Aerosol drug formulations |
| 01/14/1998 | CN1170340A Silicone compositions |
| 01/13/1998 | US5708155 Dna construct encoding a chimeric protein |
| 01/13/1998 | US5708152 Derivatives as humectants and antideposit agents |
| 01/13/1998 | US5708146 Antibodies and drugs |
| 01/13/1998 | US5708038 Method of using aloe vera as a biological vehicle |
| 01/13/1998 | US5708021 Debittered ranitidine preparation |
| 01/13/1998 | US5708017 Omeprazole pastes with thickeners |
| 01/13/1998 | US5707996 Pharmaceutical solution and methods for preparation thereof |
| 01/13/1998 | US5707975 Itraconazole or saperconazole, hydroxypropyl-b-cyclodextrin solubilizer |
| 01/13/1998 | US5707972 Polysaccharides and anesthetics and/or microbiocides for wound healing agents |
| 01/13/1998 | US5707970 Treatment of atheriosclerosis and as nutrients formed by reaction of arginine, silicate salt and inositol |
| 01/13/1998 | US5707969 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/13/1998 | US5707964 Hormone-toxin conjugate, gonadotropin-releasing hormone receptors |
| 01/13/1998 | US5707873 Method of accessing mixed lipid transport properties of a drug |
| 01/13/1998 | US5707813 Hybridization and amplification of target, phthalocyanine dye linked to oligonucleotides and solubilizing groups, fluorescence |
| 01/13/1998 | US5707670 Use of bilayer forming emulsifiers in nutritional compositions comprising divalent mineral salts to minimize off-tastes and interactions with other dietary components |
| 01/13/1998 | US5707656 Pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof |
| 01/13/1998 | US5707655 Drugs for time release agents |
| 01/13/1998 | US5707648 Oil phase, mixture of surfactants, polyoxyethylene glycol, peptides, proteins, polysaccharides |
| 01/13/1998 | US5707646 Complex formed by dispersion of drug with eudragit? and polyvinylacetal diethylaminoacetate and sugar alcohol with basic oxide |
| 01/13/1998 | US5707644 Small particle compositions for intranasal drug delivery |
| 01/13/1998 | US5707641 Formulations comprising therapeutically-active proteins or polypeptides |
| 01/13/1998 | US5707635 Containing a crosslinked polyacrylamide-type polymer and an active compound, optionally a humectant and an emollient |
| 01/13/1998 | US5707609 Graphite bar, petrochemical binder |
| 01/13/1998 | US5707603 Useful in therapeutic and diagnostic imaging |
| 01/08/1998 | WO1998000556A1 Cationic polymer and lipoprotein-containing system for gene delivery |
| 01/08/1998 | WO1998000531A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 01/08/1998 | WO1998000446A1 Oxidized oligosaccharides |
| 01/08/1998 | WO1998000438A1 Steroid bisphosphonates |
| 01/08/1998 | WO1998000178A1 Aqueous-based pharmaceutical composition |
| 01/08/1998 | WO1998000173A2 Targeted drug delivery using sulfonamide derivatives |
| 01/08/1998 | WO1998000172A2 Compositions and methods for altering the biodistribution of biological agents |
| 01/08/1998 | WO1998000171A2 Conjugates of thrombin inhibitors and endogenes carriers |
| 01/08/1998 | WO1998000170A1 Hydrolysable hydrogels for controlled release |
| 01/08/1998 | WO1998000169A1 Hydrophobic preparations containing medium chain monoglycerides |
| 01/08/1998 | WO1998000158A1 Non-aqueous polar aprotic peptide formulations |
| 01/08/1998 | WO1998000157A1 Aqueous formulations of peptides |
| 01/08/1998 | WO1998000152A1 Non-aqueous protic peptide formulations |
| 01/08/1998 | WO1998000147A1 Use of a fluid absorbing iodophor gel |
| 01/08/1998 | WO1998000146A1 Water miscible erythromycin solutions |
| 01/08/1998 | WO1998000136A1 Virginiamycin mixture |
| 01/08/1998 | WO1998000128A1 Parenteral paclitaxel in a stable non-toxic formulation |
| 01/08/1998 | WO1998000115A2 Stable drug form for oral administration and process for the preparation thereof |
| 01/08/1998 | WO1998000114A2 Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
| 01/08/1998 | WO1998000113A1 Solid solution of an antifungal agent with enhanced bioavailability |
| 01/08/1998 | WO1998000110A1 Emulsion formulations for hydrophilic active agents |
| 01/08/1998 | WO1998000096A1 Use of acrylic copolymers in cosmetics and compositions used |
| 01/08/1998 | WO1997041896A3 Inclusion complexes of aryl-heterocyclic salts |
| 01/08/1998 | WO1997033995A3 Extracellular matrix signalling molecules |
| 01/08/1998 | DE19728279A1 Ketoprofen plaster with long-term and immediate effect, |
| 01/08/1998 | DE19626431A1 Anti-alcoholic and nootropic medicaments |
| 01/08/1998 | DE19626045A1 Stabile Arzneiform zur oralen Verabreichung sowie Verfahren zur Herstellung derselben Stable drug form for oral administration and methods for preparing the same |
| 01/08/1998 | DE19625524A1 New synthetic catechol derivatives and their conjugates with active ingredients e.g. antibiotics |